Prostate Cancer - Results from #760

REVIEW UroToday

The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease, "Beyond the Abstract," by Florence K. Keane, MD; Ming-Hui Chen, PhD; and Anthony V. D’Amico, MD, PhD June 17, 2014

Preliminary ex-vivo results from a study of multispectral photoacoustic imaging of prostate cancer, "Beyond the Abstract," by Bhargava Chinni June 13, 2014

Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy, "Beyond the Abstract," by Nazareno Suardi June 13, 2014

A review of the molecular mechanisms of soy isoflavones and prostate cancer, "Beyond the Abstract," by Abeer M. Mahmoud, MD, PhD and Maarten Bosland, DVSc, PhD June 9, 2014

The cost effectiveness of MRI-driven prostate cancer detection, "Beyond the Abstract," by Maarten de Rooij June 5, 2014

High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development, "Beyond the Abstract," by Dong Lin, Alexander W. Wyatt, Colin C. Collins, and Yuzhuo Wang June 5, 2014

Full field optical coherence tomography (FFOCT) of prostate biopsies: A step towards pre-histological diagnosis? "Beyond the Abstract," by Nicolas Barry Delongchamps, MD May 30, 2014

Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo, "Beyond the Abstract," by Somanath P.R. Shenoy, PhD, FAHA May 30, 2014

A population-based observational study of practice patterns for the use of venous thromboembolism prophylaxis among men undergoing radical prostatectomy, "Beyond the Abstract," by Aaron C. Weinberg, MD May 30, 2014

Prognostic value of discs large homolog 7 transcript levels in prostate cancer, "Beyond the Abstract," by George Vasmatzis, PhD and Christian Gomez, PhD May 16, 2014

Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer, "Beyond the Abstract," by Sam Beddar, PhD, DABR, FCCPM, FAAPM May 16, 2014

Key considerations for the experimental training and evaluation of cancer odour detection dogs, "Beyond the Abstract," by Hywel C. Williams, DSc, FRCP, et al May 15, 2014

Can single positive core prostate cancer at biopsy be considered a low-risk disease after radical prostatectomy? "Beyond the Abstract," by Ricardo Kupka, MD May 9, 2014

Early removal of urethral catheter with suprapubic tube drainage versus urethral catheter drainage alone: A randomized controlled trial following robot-assisted laparoscopic radical prostatectomy, "Beyond the Abstract," by Sandip M. Prasad, MD May 8, 2014

PSA screening, lives saved, and hormonal monotherapy: It’s time to face some quietly ignored facts, "Beyond the Abstract," by Ian Haines, MBBS, FRACP, FAChPM and George L. Gabor Miklos, PhD May 6, 2014

Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells, "Beyond the Abstract," by Sanjay Gupta April 29, 2014

A possible link between bilateral orchiectomy for metastatic prostate cancer treatment and high cardiovascular risk, "Beyond the Abstract," by Konstantinos Stamatiou April 28, 2014

The pitfall of the small cell prostate carcinoma variant resulting in a false-negative bone scan and choline PET/CT study in a case of prostate cancer, "Beyond the Abstract," by Ammad Al Tamimi MD, FRCR April 25, 2014

In clinical practice, a higher cancer detection rate is possible utilizing 3D versus 2D systematic transrectal ultrasound-guided prostate biopsy, "Beyond the Abstract," by Aoun Fouad, MD April 24, 2014

A critical review of enzalutamide in the treatment of metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Ashley Freeman, MD and Jeanny B. Aragon-Ching, MD April 22, 2014

Page 39 of 57